Related by context. Frequent words. (Click for all words.) 71 Kinase Inhibitor 71 poly ADP ribose polymerase 70 MKC# MT 70 multi kinase inhibitor 70 Sapacitabine 69 PNP inhibitor 69 Belimumab 69 based pretargeting methods 69 Daclizumab 69 refractory chronic lymphocytic 69 oncolytic virus therapies 69 Initiates Phase II 69 targeting CD# 69 Epidermal Growth Factor Receptor 69 VEGFR2 inhibitor 69 XL# XL# XL# XL# 68 NS5A 68 Bafetinib 68 fibrosis IPF 67 Hepatitis C Virus HCV 67 Omacetaxine 67 sorafenib tablets 67 CCR5 antagonist 67 Epratuzumab 67 HCV protease 67 polymerase inhibitors 67 addressing idiopathic pulmonary 67 Blinatumomab 67 Completes Patient Enrollment 67 Anti Tumor 66 chemokine receptor 66 Recombinant Human 66 modulate ion channel 66 Small interfering RNAs 66 Receives Orphan Drug Designation 66 CEQ# 66 novel orally administered 66 ALN TTR 66 R sorafenib tablets 66 FLT3 66 ZFP Therapeutics 66 polymerase inhibitor 66 HER1 66 AEG# 66 hepatitis C lupus 66 non nucleoside polymerase 66 Romidepsin 66 2 methoxyestradiol 66 histone deacetylase HDAC inhibitors 66 therapeutic monoclonal antibodies 65 BiTE R 65 Darinaparsin 65 Human immunodeficiency virus 65 HIV integrase inhibitors 65 selectively inhibits 65 JAK3 65 Marcus Gronholm BP 65 MEK inhibitor 65 Meets Primary Endpoint 65 liposomal formulation 65 Temsirolimus 65 Protease Inhibitor 65 hepatitis C HCV 65 cutaneous T 65 oral antiviral 65 drug conjugate ADC 65 Potassium Chloride Sodium Ascorbate 65 gets USFDA nod 65 CD# expressing 65 YOUR LOCAL ANIMAL SHELTER 65 Antigens 65 ® bortezomib 65 Monoclonal Antibody 65 developing Zerenex TM 65 humanized anti 65 FGFR 65 Cutaneous T 65 Aurora kinase 65 B lymphocyte stimulator 65 HOW LONG WAS 65 Panzem R 65 Interferons 65 * Azixa 65 fusion inhibitor 65 RhuDex ® 65 forodesine 65 Gleevec resistant 65 Voreloxin 65 Pralatrexate 65 PTP 1B 65 nucleoside analogues 65 G Protein Coupled 64 fluoroquinolone class 64 castrate resistant prostate cancer 64 Methylnaltrexone 64 Factor VIIa 64 Hepatitis B Virus 64 MKC# 64 selective inhibition 64 dependent cellular cytotoxicity 64 novel RNAi therapeutics